HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modulation of the biologic activities of IgE-binding factor. V. The role of glycosylation-enhancing factor and glycosylation-inhibiting factor in determining the nature of IgE-binding factors.

Abstract
Glycosylation-enhancing factor (GEF) and IgE-potentiating factor were detected in culture supernatants of rat mesenteric lymph nodes (MLN) cells obtained 14 days after infection with Nippostrongylus brasiliensis (Nb), but not in supernatants of MLN cells of 8-day Nb-infected rats. Both factors were also released from T cells upon antigenic stimulation of KLH + alum-primed spleen cells. The GEF from the Nb-infected rats and KLH + alum-primed spleen cells had affinity for p-aminobenzamidine agarose and were inactivated by phenylmethylsulfonylfluoride, an inhibitor of serine proteases. These results indicate that the GEF obtained in the two systems is a serine protease and is identical to that obtained by stimulation of normal T cells with lymphocytosis-promoting factor (LPF) from Bordetella pertussis. The concomitant formation of IgE-potentiating factor and GEF by Nb infection, by antigenic simulation of KLH + alum-primed spleen cells, and by treatment of rats with Bordetella pertussis vaccine suggests that the serine protease is involved in a common pathway leading to the selective formation of IgE-potentiating factor. In contrast, glycosylation-inhibiting factor (GIF) is always found during the selective formation of IgE-suppressive factor. IgE-suppressive factor and GIF were formed by MLN cells of 8-day Nb-infected rats and KLH-CFA-primed spleen cells. GIF was detected in culture supernatants of T cell hybridomas 23A4 and 23B6, which form unglycosylated IgE-binding factors upon incubation with IgE. GIF obtained from all of these sources bound to monoclonal anti-lipomodulin. These findings indicate that GIF or lipomodulin is involved in all systems, which leads to the selective formation of IgE-suppressive factor. However, the formation of GIF was not restricted to those conditions in which IgE-suppressive factor was selectively formed. The culture supernatants of MLN cells of 14-day Nb-infected rats and antigen-stimulated KLH + alum-primed spleen cells contained a small amount of GIF, which could be detected after inactivation of GEF. It appears that T cells from these sources formed GEF and GIF, but that GEF overcame the effect of GIF on glycosylation of IgE-binding factors. The results indicate that the nature and biologic activities of IgE-binding factors are decided by the balance between GEF and GIF formed by T cells.
AuthorsM Iwata, T F Huff, K Ishizaka
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 132 Issue 3 Pg. 1286-93 (Mar 1984) ISSN: 0022-1767 [Print] United States
PMID6363537 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Annexins
  • Antibodies, Monoclonal
  • Antigens
  • Blood Proteins
  • Calcium-Binding Proteins
  • Glycoproteins
  • Lymphokines
  • Prostatic Secretory Proteins
  • Proteins
  • beta-microseminoprotein
  • immunoenhancing factor
  • immunoglobulin-binding factors
  • lipomodulin
  • Hemocyanins
  • IgE destroying enzyme
  • Peptide Hydrolases
  • keyhole-limpet hemocyanin
Topics
  • Animals
  • Annexins
  • Antibodies, Monoclonal (immunology)
  • Antigens (immunology)
  • Blood Proteins (biosynthesis, physiology)
  • Calcium-Binding Proteins
  • Glycoproteins
  • Hemocyanins
  • Hookworm Infections (immunology)
  • Hybridomas (immunology)
  • Lymph Nodes (immunology)
  • Lymphokines (metabolism, physiology)
  • Mice
  • Mice, Inbred BALB C
  • Peptide Hydrolases (biosynthesis, pharmacology)
  • Prostatic Secretory Proteins
  • Proteins (immunology)
  • Rats
  • Rats, Inbred Lew

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: